UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Nanotechnology in the treatment of inflammatory bowel diseases

Journal of Crohn's and colitis, 2014-09, Vol.8 (9), p.903-918

2014

Volltextzugriff (PDF)

The long journey of salicylates in ulcerative colitis: The past and the future

Journal of Crohn's and colitis, 2009-09, Vol.3 (3), p.149-156

2009

Volltextzugriff (PDF)

Biological agents for ulcerative colitis: Hypes and hopes

Medicinal research reviews, 2008-03, Vol.28 (2), p.201-218

2008

Volltextzugriff (PDF)

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis

World journal of gastroenterology : WJG, 2011-04, Vol.17 (14), p.1831-1835

2011

Volltextzugriff (PDF)

Medical Therapy for Crohn’s Disease: Top-Down or Step-Up?

Digestive diseases (Basel), 2007-01, Vol.25 (3), p.260-266

2007

Volltextzugriff (PDF)

Smad3 knock-out mice as a useful model to study intestinal fibrogenesis

World journal of gastroenterology : WJG, 2006-02, Vol.12 (8), p.1211

2006

Volltextzugriff (PDF)

Why does Crohn's disease usually occur in terminal ileum?

Journal of Crohn's and colitis, 2008-12, Vol.2 (4), p.352-356

Caprilli, Renzo

2008

Volltextzugriff (PDF)

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

Canadian journal of gastroenterology, 2005, Vol.19 Suppl A, p.5A

2005

Volltextzugriff (PDF)

In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?

Inflammatory bowel diseases, 2008-10, Vol.14 (Supplement), p.S226-S227

Caprilli, Renzo

2008

Volltextzugriff (PDF)

In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?

Inflammatory bowel diseases, 2008-10, Vol.14 (S2), p.S226-S227

Caprilli, Renzo

2008

Volltextzugriff (PDF)

MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent

Radiology, 2006-02, Vol.238 (2), p.517

2006

Volltextzugriff (PDF)

Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum

World journal of gastroenterology : WJG, 2006-06, Vol.12 (24), p.3933

2006

Volltextzugriff (PDF)

Inflammatory bowel diseases: clinical update of practical guidelines

Nuclear medicine communications, 2005-07, Vol.26 (7), p.649-655

2005

Volltextzugriff (PDF)

Current management of severe ulcerative colitis

Nature clinical practice. Gastroenterology & hepatology, 2007-02, Vol.4 (2), p.92-101

2007

Volltextzugriff (PDF)

Presentation of Meeting

Inflammatory bowel diseases, 2006-04, Vol.12, p.ix

Caprilli, Renzo

2006

Volltextzugriff (PDF)

In favour of early surgery in Crohn's disease: a hypothesis to be tested

Journal of Crohn's and colitis, 2011-02, Vol.5 (1), p.1-4

2011

Volltextzugriff (PDF)

Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick?

Journal of Crohn's and colitis, 2012-06, Vol.6 (5), p.621-625

2012

Volltextzugriff (PDF)

Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy

Journal of clinical virology, 2008-10, Vol.43 (2), p.180-183

2008

Volltextzugriff (PDF)

Small intestine contrast ultrasonography An Alternative to Radiology in the Assessment of Small Bowel Disease

Inflammatory bowel diseases, 2005-02, Vol.11 (2), p.146-153

2005

Volltextzugriff (PDF)

Natalizumab in the treatment of Crohn's disease

Biologics, 2008-06, Vol.2 (2), p.275-284

2008

Volltextzugriff (PDF)

Another paradox in Crohn's disease: New onset of psoriasis in a patient receiving tumor necrosis factor‐α antagonist

Inflammatory bowel diseases, 2007-08, Vol.13 (8), p.1059-1061

2007

Volltextzugriff (PDF)

Eating the enemy in Crohn's disease: an old theory revisited

Journal of Crohn's and colitis, 2010-10, Vol.4 (4), p.377-383

2010

Volltextzugriff (PDF)

Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception

Inflammatory bowel diseases, 2008-03, Vol.14 (3), p.435-436

2008

Volltextzugriff (PDF)

Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats

Digestive diseases and sciences, 2002-07, Vol.47 (7), p.1447-1457

2002

Volltextzugriff (PDF)

Dextran sulfate sodium (DSS) colitis in rats : Clinical, structural, and ultrastructural aspects

Digestive diseases and sciences, 1999-07, Vol.44 (7), p.1458-1475

1999

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(88)
Berichte
(3)
Reviews
(1)

Sprache

Englisch
(92)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Humans
(46)
Gastroenterology & Hepatology
(38)
Male
(22)
Biological And Medical Sciences
(19)
Female
(19)
Medical Sciences
(19)
Adult
(17)
Middle Aged
(16)
Ulcerative Colitis
(15)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(13)
Other Diseases. Semiology
(11)
Aged
(10)
Crohn's Disease
(10)
Infliximab
(8)
Antibodies, Monoclonal - Therapeutic Use
(6)
Crohn Disease - Diagnosis
(6)
Crohn Disease - Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nanotechnology in the treatment of inflammatory bowel diseases

The long journey of salicylates in ulcerative colitis: The past and the future

Biological agents for ulcerative colitis: Hypes and hopes

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis

Medical Therapy for Crohn’s Disease: Top-Down or Step-Up?

Smad3 knock-out mice as a useful model to study intestinal fibrogenesis

Why does Crohn's disease usually occur in terminal ileum?

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?

In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?

MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent

Mesenteric adenitis caused by Yersinia pseudotubercolosis in a patient subsequently diagnosed with Crohn's disease of the terminal ileum

Inflammatory bowel diseases: clinical update of practical guidelines

Current management of severe ulcerative colitis

Presentation of Meeting

In favour of early surgery in Crohn's disease: a hypothesis to be tested

Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick?

Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy

Small intestine contrast ultrasonography An Alternative to Radiology in the Assessment of Small Bowel Disease

Natalizumab in the treatment of Crohn's disease

Another paradox in Crohn's disease: New onset of psoriasis in a patient receiving tumor necrosis factor‐α antagonist

Eating the enemy in Crohn's disease: an old theory revisited

Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception

Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats

Dextran sulfate sodium (DSS) colitis in rats : Clinical, structural, and ultrastructural aspects

Suchergebnisse filtern